Alexander Aristarkhov
CSO at ALTACELLS
Director of External R&D, Innovations | Science and Technology Consultant | Business Development
Director of R&D, Strategic Research, Business, and Investment Consultant with a unique combination of academic expertise as Harvard faculty and a record of development industrial research, diagnostic platforms, and pharmaceutical modalities; a scientific leader with unbiased scientific and technological vision focused on conversion of discovery into validated assets. Generates platform ideas, and product and services concepts; efficient Project and Alliances Manager provided scientific expertise and business due diligence and implementation.

Core Strengths: ability to see the big picture, formulate the key problem, analytical mind, creativity and passion for setting direction and strategy for solutions, deciding on the path forward, and executing accordingly for patient interest or customer’s unmet needs and challenges; firmly focused on deep understanding the emerging science and its practical business applications. 

Specialties: Research Management | Technology Development | Strategic Initiatives for New Product | Assay Development | Cell Biology | RNA Therapeutics and Diagnostics, mRNA, ncRNA, miRNA, lncRNA | Stem Cells and Cell Therapeutics |Extracellular Vesicles, Exosomes | Microbiome |Drug Discovery | Preclinical Development | Biomarkers | Cancer | Strategic Alliances | Due Diligence, Company Evaluation | Investment Strategy

aaristarkhov@msn.com
ALTACELLS
CSO
RNASolutions
Biopharma Consultant on technology, R&D and business development, investment stategy
GE Healthcare
https://www.linkedin.com/company/gehealthcare
https://media-exp1.licdn.com/dms/image/C4D0BAQEnKdGryPPiJw/company-logo_100_100/0/1588611370360?e=1655942400&v=beta&t=qizxOYB7k2tNcupvuXPEzgD0bv-_QMvaLEkO8Bgr3vs
New Technologies Assessment and Development Leader
Advirna
https://www.linkedin.com/company/advirna
https://media-exp1.licdn.com/dms/image/C4E0BAQH_fjUaAule1A/company-logo_100_100/0/1519892352462?e=1655942400&v=beta&t=tNoucuv4C3UlpH74wgka7MP-ZWc6OdJMTe92frnAYIM
Sr. Director of Technology Development
Moderna Therapeutics
https://www.linkedin.com/company/modernatx
Cambridge ma
https://media-exp1.licdn.com/dms/image/C4D0BAQG0VIqVddqc1Q/company-logo_100_100/0/1625142226484?e=1655942400&v=beta&t=APz3bTta1X3tUuAYhMdME-PCWXHKV59wLQgoOxNBgDY
Technology Development Leader
Merck Group
https://www.linkedin.com/company/merck-group
https://media-exp1.licdn.com/dms/image/C4D0BAQE2ZjeYdi2Zsw/company-logo_100_100/0/1519856500274?e=1655942400&v=beta&t=s0g5VeQPFzP7ZTvimDow6IDvefc6hYqlHVU39T7xsGA
Strategic Science and Technology consultant
Exiqon
https://www.linkedin.com/company/exiqon
https://media-exp1.licdn.com/dms/image/C510BAQHgK_M8l2qo8w/company-logo_100_100/0/1519856033271?e=1655942400&v=beta&t=rB8ZKITZpzXHrr0ciWAqTWlmxHcd5IpGuG_gyhMDSIw
Director Science &Technology, Head of Applications
Agenus
https://www.linkedin.com/company/agenus
https://media-exp1.licdn.com/dms/image/C4E0BAQGJFhnUcAHGuQ/company-logo_100_100/0/1519869989746?e=1655942400&v=beta&t=EgZ31RQHSNDxg0G9e-GnliELsQGPhtKBlCYqbv3f6IY
Associate Director of Biochemistry and Cell Biology
Applied Biosystems
https://www.linkedin.com/company/life_technologies
https://media-exp1.licdn.com/dms/image/C4E0BAQGnGeodjQKFaA/company-logo_100_100/0/1519855866331?e=1655942400&v=beta&t=rhPPzlHhagfjckb3aNWYZAtZL_3tGJ-RHhZg7VnzPyY
Head of Cell Biology Systems R&D, Advanced Research Technologies Division
Harvard Medical School
https://www.linkedin.com/company/harvard-medical-school
https://media-exp1.licdn.com/dms/image/C4E0BAQFpnx840JxXEA/company-logo_100_100/0/1519856407255?e=1655942400&v=beta&t=RY62HtjQ83F8wz5fxHxyefDJsKSzOUej_CzqEJf6g74
Research Assistant Professor, Instructor in Cell Biology, Dept. of Cell Biology
Harvard Medical School
https://www.linkedin.com/company/harvard-medical-school
https://media-exp1.licdn.com/dms/image/C4E0BAQFpnx840JxXEA/company-logo_100_100/0/1519856407255?e=1655942400&v=beta&t=RY62HtjQ83F8wz5fxHxyefDJsKSzOUej_CzqEJf6g74
Research Fellow, Dept. of Microbiology and Molecular Genetics
Two Postdoctoral trainings
https://media-exp1.licdn.com/dms/image/C4E0BAQFpnx840JxXEA/company-logo_100_100/0/1519856407255?e=1655942400&v=beta&t=RY62HtjQ83F8wz5fxHxyefDJsKSzOUej_CzqEJf6g74
Harvard Medical School
https://www.linkedin.com/school/harvard-medical-school/
 “Short MBA,” Babson Executive Education  
https://media-exp1.licdn.com/dms/image/C4E0BAQG9uoVqHj4dSg/company-logo_100_100/0/1590084332779?e=1655942400&v=beta&t=jSWGhvdSAICO_LtAjLb4sDj0TwbnfVwp8AYu9eBNeFY
Babson College
https://www.linkedin.com/school/babson-college/
Doctor of Philosophy (Ph.D.)
Russian Academy of Science (RAS)
Master of Science (M.Sc.)
https://media-exp1.licdn.com/dms/image/C560BAQFafJR7i-j8EA/company-logo_100_100/0/1557584831531?e=1655942400&v=beta&t=kyJQSTY6UVH3VazsrQb_vvfVW5_ScR6b-yAJQLoTq9Q
Lomonosov Moscow State University (MSU)
https://www.linkedin.com/school/%D0%BC%D0%BE%D1%81%D0%BA%D0%BE%D0%B2%D1%81%D0%BA%D0%B8%D0%B9-%D0%B3%D0%BE%D1%81%D1%83%D0%B4%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D0%B9-%D1%83%D0%BD%D0%B8%D0%B2%D0%B5%D1%80%D1%81%D0%B8%D1%82%D0%B5%D1%82-%D0%B8%D0%BC.-%D0%BC.%D0%B2.-%D0%BB%D0%BE%D0%BC%D0%BE%D0%BD%D0%BE%D1%81%D0%BE%D0%B2%D0%B0-%D0%BC%D0%B3%D1%83-/
https://www.linkedin.com/in/sophia-vaulina-0349732b
Lexington, MA
Sophia Vaulina
COO & Founder at 4Schoolers, LLC
https://www.linkedin.com/in/steve-jarding-b2193242
Rapid City, SD
Steve Jarding
Professor at Harvard University
https://www.linkedin.com/in/zhijingwu0127
Newton Highlands, MA
Zhijing Wu
Founder & President
https://www.linkedin.com/in/sarah-duyos-81761b14
Oldsmar, FL
Sarah Duyos
Senior Actuary at Verscend
https://ru.linkedin.com/in/sofia-sazonova-61302974
Russia
Sofia Sazonova
scientist, software engineer
https://www.linkedin.com/in/natalia-mast-7933a174
Cleveland, OH
Natalia Mast
research Scientist at CWRU
https://de.linkedin.com/in/kate-kutsenok-ba5615b9
Munich
Kate Kutsenok
PhD student at Ludwig-Maximilians-Universität München
https://www.linkedin.com/in/anvar-gilmanov
Columbia, MD
Anvar Gilmanov
Senior Engineer at Combustion Science & Engineering, Inc.
https://jp.linkedin.com/in/yukio-nakano-24643319
Tokyo, Japan
YUKIO NAKANO
Assistant Professor at Doshisha University
https://de.linkedin.com/in/maria-sidorova-7145a24a
Hannover
Maria Sidorova
Senior Research Scientist, Project Manager
https://ru.linkedin.com/in/dmitry-shulga-3b68a71a
Russia
Dmitry Shulga
Data science in Drug Discovery, PhD, MBA
https://lt.linkedin.com/in/anna-aristarkhova-moldavskaja-152655219
Klaipėdos, Lithuania
Anna Aristarkhova-Moldavskaja
--
https://www.linkedin.com/in/varlikkiziloren
Denver Metropolitan Area
Varlik Kiziloren
Business Analytics & International Energy Markets
https://www.linkedin.com/in/nathanehowe
Washington, DC
Nathan Howe
Corporate & Securities Attorney | Representing Companies in M&A Transactions, Corporate Governance, Securities, and Contracts
https://nl.linkedin.com/in/dinara-soorbekova
Leiden
Dinara Soorbekova
European & International Business law,  Legal Counsel, LL.M.
https://fr.linkedin.com/in/natasha-de-peyrecave-a90a93
France
Natasha de Peyrecave
Medical Affairs Head Axial Spondyloarthritis at UCB
https://se.linkedin.com/in/pavel-grozny-119506140
Stockholm
Pavel Grozny
Global Content Curator at Storytel AB
https://ru.linkedin.com/in/kirill-peskov-55819527
Moscow
Kirill Peskov
CEO at M&S Decisions
https://ca.linkedin.com/in/steven-webb-93661714
Saskatoon, SK
Steven Webb
Executive Director and Chief Executive Officer at Global Institute for Food Security
https://www.linkedin.com/in/jan-rosenbaum-3bb9163
Cincinnati Metropolitan Area
Jan Rosenbaum
President, Chief Executive Officer, & CSO at Kurome Therapeutics, Inc.
Michael Kallelis
      
          



            
              
        
              
  

    
        I worked with Alex in 2005-2007, establishing a US presence for Exiqon, a Danish gene expression analysis company.  Alex was a key speaker, R&D leader and Strategic Marketing contributor for our LNA microRNA technology. This effort established a significant network of early adopters and facilitated rapid sales growth in the US.  This successful effort eventually enabled a successful IPO, in the Spring of 2007.  In his role, Alex became a strong advocate of our microRNA profiling technology for use in companion diagnostics.  During this time, he passionately established and led our US R&D and Applications team.  His early efforts and scientific perspective were critical to our success and greatly appreciated by me as we established our US presence.  
https://ca.linkedin.com/in/alexander-aristarkhov-641b9b92
Montreal, QC
Alexander Aristarkhov
Licensed Realtor
https://ru.linkedin.com/in/alexander-aristarkhov-2089103
Russia
Alexander Aristarkhov
main specialist at Administration of Krasnodar region
https://www.linkedin.com/in/alexander-aristarkhov-602b08221
Boston, MA
Alexander Aristarkhov
--
https://www.linkedin.com/in/alexander-aristarkhov-19576a6
Woburn, MA
Alexander Aristarkhov
Director at Exiqon